MedTrace Logo

Clinical Utility of Neuromodulation on Tinnitus

NCT05674435 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 26

Last updated 2023-01-06

No results posted yet for this study

Summary

The aim of the present narrative review is to one of the first to critically evaluate the clinical effectiveness of neuromodulation as a therapeutic option for patients with tinnitus. Our method involves conducting a systemic review and the findings reported following PRISMA statement. Pubmed, Cochrane database and Google Scholar databases literature search was conducted for articles reporting the use of neuromodulatory interventions on tinnitus patients. Each article was evaluated using the Cochrane risk of bias tool.

Conditions

  • Tinnitus

Sponsors & Collaborators

  • Hearing and Language Healthcare Center, China Medical University Hsinchu Hospital, Taiwan

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2022-06-30
Completion
2022-09-30

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05674435 on ClinicalTrials.gov